Character Biosciences
Developing precision therapies for progressive age-related eye diseases.
Company facts
- Founded
- 2018
- Employees
- 48
- Headquarters
- United States
- CEO
- Cheng Zhang
- Type
- Private
- Funding
- Series B · $113M · 2025
About
Character Bio focuses on transforming eye care with precision medicine. They are committed to patient safety and privacy, emphasizing ethical transparency in their science. Character Bio is dedicated to patient diversity and targets polygenic diseases to make the greatest health impact. Their mission is driven by a team of experts from the realms of drug discovery, development, data science, and clinical research. By leveraging this expertise, Character Bio aims to significantly improve patient lives through innovative solutions tailored to individual needs. Character Bio’s approach combines advanced methodologies in precision medicine with a strong dedication to ethical practices in healthcare. They prioritize the creation of inclusive healthcare solutions that cater to a diverse patient population. Their innovations in eye care are grounded in rigorous scientific research and a commitment to ethical transparency, ensuring that patients can trust in the methods that are employed to improve their health outcomes. The team encourages individuals to join them in their mission to make a transformative impact on health care.